Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts

Author： Tamura M.   Chen Y.-J.   Howard E.F.   Tanner M.   Landon E.J.   Myers P.R.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.386, Iss.2, 1999-12, pp. : 289-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of metabolic and cardiac dysfunctions by insulin sensitizers and angiotensin receptor blocker in rat model of type 2 diabetes mellitus

By Hussein Abd El-Aziz M.   Omar Nisereen M.   Sakr Hussein   Elsamanoudy Ayman Z.   Shaheen Dalia  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 3, 2011-03 ,pp. : 216-226

NRC Research Press

Access to resources Recommend Favorite

Luteolin Antagonizes Angiotensin II-Dependent Proliferation and Collagen Synthesis of Cultured rat Cardiac Fibroblasts

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 5, 2015-05 ,pp. : 430-439

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin II Type 1 and Type 2 Receptor-induced Cell Signaling

By  

Current Pharmaceutical Design, Vol. 19, Iss. 17, 2013-05 ,pp. : 2988-2995

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin II type 2 receptor agonists: where should they be applied?

By Verdonk Koen   Danser A H Jan   van Esch Joep H M  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 501-513

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II type 2 receptor agonists – where should they be applied?

By Steckelings Ulrike Muscha   Unger Thomas  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 763-766

Informa Healthcare

Access to resources Recommend Favorite